Amphastar Pharmaceuticals (AMPH) PT Lowered to $22 at BMO Capital
Tweet
Share
E-mail
Get Alerts AMPH Hot Sheet
Price: $23.84 +0.42%
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
BMO Capital analyst Gary Nachman lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $22.00 (from $23.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Telenor ASA (TEL:NO) (TELNY) to Neutral
- The Campbell's Co. (CPB) PT Lowered to $20 at Jefferies, 'we remain cautious'
- Climb Bio (CLYM) PT Raised to $32 at BTIG
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
